Rodolfo Valdés

634 total citations
54 papers, 382 citations indexed

About

Rodolfo Valdés is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Rodolfo Valdés has authored 54 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 17 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Biotechnology. Recurrent topics in Rodolfo Valdés's work include Transgenic Plants and Applications (17 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Viral Infectious Diseases and Gene Expression in Insects (14 papers). Rodolfo Valdés is often cited by papers focused on Transgenic Plants and Applications (17 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Viral Infectious Diseases and Gene Expression in Insects (14 papers). Rodolfo Valdés collaborates with scholars based in Cuba, China and Thailand. Rodolfo Valdés's co-authors include José A. Cremata, Jorge Gavilondo, Marta Ayala, M. Arias Rodríguez, Ernesto González, Rolando Páez, Carlos Borroto, Merardo Pujol, Leonardo D. Gómez and Alberto Leyva and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Rodolfo Valdés

48 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodolfo Valdés Cuba 12 236 129 81 81 54 54 382
Asad Ullah Pakistan 14 400 1.7× 70 0.5× 107 1.3× 82 1.0× 121 2.2× 25 473
Tahreem Zaheer Pakistan 8 241 1.0× 24 0.2× 87 1.1× 71 0.9× 81 1.5× 12 310
Calli Lear United States 6 147 0.6× 72 0.6× 31 0.4× 92 1.1× 213 3.9× 6 698
Marielena Mata United States 6 86 0.4× 103 0.8× 9 0.1× 164 2.0× 46 0.9× 6 384
Olga L. Voronina Russia 11 151 0.6× 75 0.6× 30 0.4× 19 0.2× 52 1.0× 65 363
James Pettitt United States 10 203 0.9× 176 1.4× 75 0.9× 87 1.1× 165 3.1× 14 711
Juine-Ruey Chen Taiwan 8 222 0.9× 28 0.2× 80 1.0× 132 1.6× 340 6.3× 13 523
Sihong Xu China 11 133 0.6× 27 0.2× 12 0.1× 27 0.3× 48 0.9× 46 401
Maryam Shafaati Iran 10 235 1.0× 21 0.2× 8 0.1× 73 0.9× 160 3.0× 39 465
Rute Castro Portugal 9 173 0.7× 50 0.4× 23 0.3× 16 0.2× 20 0.4× 19 287

Countries citing papers authored by Rodolfo Valdés

Since Specialization
Citations

This map shows the geographic impact of Rodolfo Valdés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodolfo Valdés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodolfo Valdés more than expected).

Fields of papers citing papers by Rodolfo Valdés

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodolfo Valdés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodolfo Valdés. The network helps show where Rodolfo Valdés may publish in the future.

Co-authorship network of co-authors of Rodolfo Valdés

This figure shows the co-authorship network connecting the top 25 collaborators of Rodolfo Valdés. A scholar is included among the top collaborators of Rodolfo Valdés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodolfo Valdés. Rodolfo Valdés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González, Marcos, Rodolfo Valdés, Yassel Ramos, et al.. (2020). Monoclonal antibody against Nile tilapia (Oreochromis niloticus) IgM heavy chain: A valuable tool for detection and quantification of IgM and IgM+ cells. Fish & Shellfish Immunology. 110. 44–54. 18 indexed citations
2.
Leyva, Alberto, et al.. (2017). An ELISA for quantification of recombinant human EGF in production process samples, serum and urine. Biologicals. 51. 12–17. 1 indexed citations
3.
Valdés, Rodolfo, et al.. (2016). Propuesta de modelo para el consentimiento informado en pacientes que requieren tratamiento quirúrgico. SHILAP Revista de lepidopterología.
4.
Martínez, Yamila, et al.. (2014). Validation of a Chromogenic Substrate Method for Biological Activity Quantification of Streptokinase. BioProcessing Journal. 13(3). 49–59. 1 indexed citations
5.
Valdés, Rodolfo, et al.. (2013). Nosocomial Ventilator-Associated Pneumonia in Cuban Intensive Care Units: Bacterial Species and Antibiotic Resistance. MEDICC Review. 15(2). 26–26. 15 indexed citations
6.
González, Marcos, et al.. (2013). Sustitución del medio suplementado con suero en la congelación de células del hibridoma CB.Hep-1 y la producción del anticuerpo monoclonal. Biotecnología aplicada. 30(1). 57–62. 1 indexed citations
8.
Valdés, Rodolfo, et al.. (2012). Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units. The Brazilian Journal of Infectious Diseases. 16(1). 45–51. 15 indexed citations
9.
Valdés, Rodolfo, et al.. (2012). Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units. The Brazilian Journal of Infectious Diseases. 16(1). 45–51. 4 indexed citations
11.
Leyva, Alberto, et al.. (2011). Novel and sensitive ELISA for the rapid quantification of recombinant p64K protein. Journal of Pharmaceutical and Biomedical Analysis. 55(3). 403–408. 3 indexed citations
12.
Valdés, Rodolfo, et al.. (2010). Quality Risk Management Application Review in Pharmaceutical and Biopharmaceutical Industries. BioProcessing Journal. 9(1). 26–37. 5 indexed citations
13.
Valdés, Rodolfo, et al.. (2010). Using quality risk management in the plantibody HB-01 manufacturing by transgenic tobacco Plants for vaccine production. Latin American Journal of Pharmacy. 3 indexed citations
14.
Núñez, Eutímio Gustavo Fernández, et al.. (2008). Characterization and Scale-Up of Cyanogen Bromide Chemical Activation of Sepharose CL-4B in a Stirred Tank Reactor to Purify the rHBsAg. International Journal of Chemical Reactor Engineering. 6(1). 1 indexed citations
15.
Núñez, Eutímio Gustavo Fernández, et al.. (2008). Rapid Development and Optimization of Tablet Manufacturing Using Statistical Tools. AAPS PharmSciTech. 9(2). 620–627. 3 indexed citations
16.
Valdés, Rodolfo, et al.. (2005). Production of an anti-HBsAg mouse IgG-2bk monoclonal antibody in hollow fiber bioreactors using different cell culture media and operation modes. Biotecnología aplicada. 22(2). 112–116. 1 indexed citations
17.
Valdés, Rodolfo, et al.. (2001). Stirrer tank: an appropriate technology to immobilize the CB.Hep-1 monoclonal antibody for immunoaffinity purification. Journal of Chromatography B Biomedical Sciences and Applications. 754(1). 77–83. 4 indexed citations
18.
Valdés, Rodolfo, et al.. (1995). Sendai virus removal and inactivation during monoclonal antibody purification. Biotecnología aplicada. 12(2). 115–119. 1 indexed citations
19.
Duarte, Carlos A., Marinieve Montero, Rodolfo Valdés, et al.. (1994). Multiepitope Polypeptide of the HIV-1 Envelope Induces Neutralizing Monoclonal Antibodies against V3 Loop. AIDS Research and Human Retroviruses. 10(3). 235–243. 39 indexed citations
20.
Valdés, Rodolfo, et al.. (1994). Caracterización de anticuerpos monoclonales contra el antígeno de superficie del virus de la hepatitis B. Biotecnología aplicada. 11(3). 219–224. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026